Growth hormone deficiency, bullying victimization, and associations with treatment status: a pediatric case–control study
Journal of Pediatric Psychology · 01.07.2026 · 51 (7) · 612-620
DOI: 10.1093/jpepsy/jsag022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Psychology, online erschienen am 17.03.2026. Verfasst von Zumrut Kocabey Sutcu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Bullying, Crime Victims, Human Growth Hormone, Growth Disorders. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Objective
Short stature affects approximately 3% of children and often leads to psychosocial challenges, including peer bullying. While growth hormone therapy effectively treats physical aspects of growth hormone deficiency, its protective effects against bullying victimization remain understudied.
Methods
This case–control study included 317 children aged 9–18 years: 108 newly diagnosed with growth hormone deficiency (untreated), 103 receiving growth hormone treatment (≥1 year), and 106 healthy controls. Participants completed the Olweus Bully/Victim Questionnaire, Rosenberg Self-Esteem Scale, Revised Child Anxiety and Depression Scale, and Strengths and Difficulties Questionnaire. Demographic and clinical data were collected through standardized interviews and medical records.
Results
Bullying victimization rates differed significantly among groups (p = .005). Newly diagnosed children showed the highest victimization rate (34.3%), followed by treated children (24.3%) and controls (15.1%). Treated children demonstrated significantly lower depressive affect scores (1.17 ± 0.95) compared to newly diagnosed children (2.2 ± 1.19, p = .001) and higher prosocial behavior scores (8.06 ± 2.09 vs. 7.08 ± 2.27, p = .001). Among treated children, bullying victims showed significantly compromised psychological functioning compared to non-victims, including lower self-esteem (27.52 ± 6.0 vs. 31.12 ± 5.44, p = .005) and higher anxiety–depression scores (48.88 ± 19.78 vs. 35.13 ± 23.81, p = .008).
Conclusions
Growth hormone therapy is associated with reduced peer bullying victimization in children with growth hormone deficiency. The stepwise pattern observed across treatment groups suggests that treatment status relates to psychosocial outcomes extending beyond physical growth. These findings support early diagnosis and comprehensive care approaches addressing both endocrine and psychosocial aspects of growth hormone deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Endocrinology Department, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
- Child and Adolescent Psychiatry Department, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
ORCID-Profile: Zumrut Kocabey Sutcu, Yasin Caliskan, Emel Hatun Aytaç Kaplan
Zitieren
APA
Kocabey Sutcu, Z., Caliskan, Y., & Aytaç Kaplan, E. H. (2026). Growth hormone deficiency, bullying victimization, and associations with treatment status: a pediatric case–control study. Journal of Pediatric Psychology, 51(7), 612-620. https://doi.org/10.1093/jpepsy/jsag022
Vancouver
Kocabey Sutcu Z, Caliskan Y, Aytaç Kaplan EH. Growth hormone deficiency, bullying victimization, and associations with treatment status: a pediatric case–control study. Journal of Pediatric Psychology. 2026;51(7):612-620. doi:10.1093/jpepsy/jsag022
BibTeX
@article{KocabeySutcu2026,
author = {Kocabey Sutcu, Zumrut and Caliskan, Yasin and Aytaç Kaplan, Emel Hatun},
title = {Growth hormone deficiency, bullying victimization, and associations with treatment status: a pediatric case–control study},
journal = {Journal of Pediatric Psychology},
year = {2026},
volume = {51},
number = {7},
pages = {612--620},
doi = {10.1093/jpepsy/jsag022}
}
EUVIMED